ArticleCEN case reports2025

Reduction of polycystic kidney and liver volumes in a patient with tolvaptan-resistant autosomal dominant polycystic kidney disease and acromegaly during lanreotide therapy.

Shun Takenaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.